Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQHealth CareMedical DevicesSnapshot 2026-07-09
Reading LMRI? Create a free portfolio, then add this holding for ongoing Reports and tracking. No credit card.
Create your account →NASDAQHealth CareMedical DevicesSnapshot 2026-07-09
Reading LMRI? Create a free portfolio, then add this holding for ongoing Reports and tracking. No credit card.
Create your account →Warn: Management is running behind on a stated commitment.
Lumexa Imaging aims for revenue near $1.07 billion in 2026. Profit targets are $234 to $242 million in adjusted EBITDA. The company grows by partnering with hospitals and expanding imaging centers. Earnings per share are expected around $0.74 in 2026.
The company has missed earnings recently and faces elevated risks. New financial obligations may pressure cash flow. If revenue or profit targets slip, growth could stall.
The stock price is about 55% below our valuation level near $27. The market may be cautious due to recent earnings misses and financial risks, while our view expects the company to meet its revenue and profit goals.
Breaks if: Adjusted EBITDA falls below $234 million in 2026
Lumexa Imaging aims to achieve Adjusted EBITDA between $234 and $242 million for the fiscal year 2026.
Breaks if: EPS falls below $0.71 per share in 2026
Breaks if: No new partnerships or JV expansions announced in 2026
Breaks if: Annual revenue falls below $1.045 billion in 2026
Lumexa Imaging aims to achieve consolidated revenues between $1.045 and $1.097 billion for the fiscal year 2026.
Stated in 3 of last 3 quarters. Revenue for 2026-Q1 was $252.537 million. The company has consistently reiterated its revenue guidance for 2026, but with only one quarter's data, the trajectory towards the $1.045 to $1.097 billion target is still unfolding.
“Lumexa Imaging continues to expect: Consolidated revenues of $1.045 to $1.097 billion.”
“the company is reiterating its outlook for the year ending December 31, 2026. Lumexa Imaging continues to expect: Consolidated revenues of $1.045 to $1.097 billion.”
“For the year ending December 31, 2026, Lumexa Imaging expects: Consolidated revenues of $1.045 to $1.097 billion.”
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.